NCT00525122

Brief Summary

Hypothesis: What is the natural course after treatment with radioactive iodine in patients with hyperthyroidism? What are the determinants for the development of acute hypo- or hyperthyroidism after treatment with radioactive iodine without antithyroid drugs?

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 4, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 5, 2007

Completed
Last Updated

May 22, 2008

Status Verified

May 1, 2008

First QC Date

September 4, 2007

Last Update Submit

May 21, 2008

Conditions

Hyperthyroidism

Keywords

hyperthyroidismradioactive iodineantithyroid drugsHyperthyroidism, treatment with radioactive iodine without antithyroid drugs

Study Arms (1)

1

Patients with hyperthyroidism who are will be treated with radioactive iodine.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of 18 years and older with hyperthyroidism who are eligible for treatment with radioactive iodine.

You may qualify if:

  • Patients wth hyperthyroidism who are eligible for treatment with radioactive iodine
  • Age \> 18 years

You may not qualify if:

  • Severe ophthalmopathy
  • Pregnancy or wish to pregnancy on short term
  • Breastfeeding
  • Patients already treated with radioactive iodine
  • Known cardiovascular diseases or other severe comorbidity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MCRZ

Rotterdam, South Holland, 3075 EA, Netherlands

RECRUITING

MeSH Terms

Conditions

Hyperthyroidism

Condition Hierarchy (Ancestors)

Thyroid DiseasesEndocrine System Diseases

Study Officials

  • A. Berghout, MD, PhD

    Medisch Centrum Rijnmond-Zuid, Netherlands

    PRINCIPAL INVESTIGATOR

  • C. van Noord, MD

    Medisch Centrum Rijnmond-Zuid, Netherlands

    PRINCIPAL INVESTIGATOR

Central Study Contacts

A. Berghout, MD, PhD

CONTACT

0031 10 2913368BerghoutA@mcrz.nl

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 4, 2007

First Posted

September 5, 2007

Study Start

September 1, 2007

Last Updated

May 22, 2008

Record last verified: 2008-05

Locations

NL(1)